158 related articles for article (PubMed ID: 30046645)
1. Novel
Margraf RL; Durtschi J; Krock B; Newcomb TM; Bonkowsky JL; Voelkerding KV; Bayrak-Toydemir P; Lutz RE; Swoboda KJ
Child Neurol Open; 2018; 5():2329048X18789282. PubMed ID: 30046645
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
[TBL] [Abstract][Full Text] [Related]
3. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
[TBL] [Abstract][Full Text] [Related]
4. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
[TBL] [Abstract][Full Text] [Related]
5. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease.
Shiihara T; Watanabe M; Moriyama K; Uematsu M; Sameshima K
Brain Dev; 2015 Apr; 37(4):455-8. PubMed ID: 25043250
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the PLP1 gene residue p. Gly198 as the molecular basis of Pelizeaus-Merzbacher phenotype.
Hoffman-Zacharska D; Kmieć T; Poznański J; Jurek M; Bal J
Brain Dev; 2013 Oct; 35(9):877-80. PubMed ID: 23245814
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional study of novel PLP1 mutations in Chinese patients with Pelizaeus-Merzbacher disease.
Xie H; Feng H; Ji J; Wu Y; Kou L; Li D; Ji H; Wu X; Niu Z; Wang J; Jiang Y
Brain Dev; 2015 Sep; 37(8):797-802. PubMed ID: 25491635
[TBL] [Abstract][Full Text] [Related]
8. Mutation of Proteolipid Protein 1 Gene: From Severe Hypomyelinating Leukodystrophy to Inherited Spastic Paraplegia.
Khalaf G; Mattern C; Begou M; Boespflug-Tanguy O; Massaad C; Massaad-Massade L
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885014
[TBL] [Abstract][Full Text] [Related]
9. Further genotype-phenotype correlation emerging from two families with PLP1 exon 4 skipping.
Biancheri R; Grossi S; Regis S; Rossi A; Corsolini F; Rossi DP; Cavalli P; Severino M; Filocamo M
Clin Genet; 2014 Mar; 85(3):267-72. PubMed ID: 23711321
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2.
Noetzli L; Sanz PG; Brodsky GL; Hinckley JD; Giugni JC; Giannaula RJ; Gonzalez-Alegre P; Di Paola J
Gene; 2014 Jan; 533(1):447-50. PubMed ID: 24103481
[TBL] [Abstract][Full Text] [Related]
11. Proteolipid protein 1 gene mutation in nine patients with Pelizaeus-Merzbacher disease.
Wang JM; Wu Y; Wang HF; Deng YH; Yang YL; Qin J; Li XY; Wu XR; Jiang YW
Chin Med J (Engl); 2008 Sep; 121(17):1638-42. PubMed ID: 19024090
[TBL] [Abstract][Full Text] [Related]
12. A novel PLP1 mutation further expands the clinical heterogeneity at the locus.
Hand CK; Bernard G; Dubé MP; Shevell MI; Rouleau GA
Can J Neurol Sci; 2012 Mar; 39(2):220-4. PubMed ID: 22343157
[TBL] [Abstract][Full Text] [Related]
13. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
Inoue K
Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
[TBL] [Abstract][Full Text] [Related]
14. Partial PLP1 deletion causing X-linked dominant spastic paraplegia type 2.
Matsufuji M; Osaka H; Gotoh L; Shimbo H; Takashima S; Inoue K
Pediatr Neurol; 2013 Dec; 49(6):477-81. PubMed ID: 24095575
[TBL] [Abstract][Full Text] [Related]
15. PLP1 gene analysis in 88 patients with leukodystrophy.
Martínez-Montero P; Muñoz-Calero M; Vallespín E; Campistol J; Martorell L; Ruiz-Falcó MJ; Santana A; Pons R; Dinopoulos A; Sierra C; Nevado J; Molano J
Clin Genet; 2013 Dec; 84(6):566-71. PubMed ID: 23347225
[TBL] [Abstract][Full Text] [Related]
16. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
17. Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene.
Liu B; Chen L; Sun J; Zhang L; Chen M; Qian Y; Wang Y; Yan K; Hou L; Huang Y; Zhang D; Xu Y; Yu J; Zhang J; Dong M
Stem Cell Res; 2020 May; 45():101791. PubMed ID: 32402715
[TBL] [Abstract][Full Text] [Related]
18. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
Lossos A; Elazar N; Lerer I; Schueler-Furman O; Fellig Y; Glick B; Zimmerman BE; Azulay H; Dotan S; Goldberg S; Gomori JM; Ponger P; Newman JP; Marreed H; Steck AJ; Schaeren-Wiemers N; Mor N; Harel M; Geiger T; Eshed-Eisenbach Y; Meiner V; Peles E
Brain; 2015 Sep; 138(Pt 9):2521-36. PubMed ID: 26179919
[TBL] [Abstract][Full Text] [Related]
19. PLP1 gene mutations cause spastic paraplegia type 2 in three families.
Yao L; Zhu Z; Zhang C; Tian W; Cao L
Ann Clin Transl Neurol; 2023 Mar; 10(3):328-338. PubMed ID: 36622199
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
